Chlamydia Screening Rates among Pregnancy Test Only Visits in Region I, 2005-2009 Andee Krasner, MPH Region I IPP Infrastructure.

Slides:



Advertisements
Similar presentations
The Sexual Health Needs of Youth in Tobago Paper presented at the Centre for Caribbean Medicine Conference, Centre for Caribbean Medicine Conference, St.
Advertisements

© March, In Their Own Right, 2002The Alan Guttmacher Institute (AGI) Why Worry About Men? Addressing mens sexual and reproductive health will help.
DIVERSE COMMUNITIES, COMMON CONCERNS: ASSESSING HEALTH CARE QUALITY FOR MINORITY AMERICANS FINDINGS FROM THE COMMONWEALTH FUND 2001 HEALTH CARE QUALITY.
List of figure titles 1.Estimated percentage of people aged 20 years or older with diagnosed and undiagnosed diabetes, by age group, United States, 2005–2008.
Effort to Initiate a Chlamydia Prevalence Study within a Managed Care Organization in Philadelphia Pamela G. Nathanson, Dorothy Mann Family Planning Council,
State Report Region V IPP Advisory Committee Meeting June 9-10, 2010.
Michigan Adolescent Screening Project- Community Partnerships MDCH.
Research activities in Orange Farm Bertran Auvert INSERM University of Versailles, France Country update meeting on scaling - up of male circumcision programmes.
Abortion Seeking Behavior Among Ghanaian Women Presented by Aparna Sundaram, PhD Guttmacher Institute January 30, 2013.
Rose Wilcher November 19, 2008 Strategic Considerations for Strengthening the Integration of FP and HIV Service Delivery Programs.
Contraception/Pregnancies MTN 020. Why do we care? Participants must come off product during pregnancy and breastfeeding – Studies of dapivirine in pregnant.
Revision of Region II IPP Screening Criteria May 16, 2007 Region II IPP Advisory Committee Meeting Cicatelli Associates Inc. New York City.
Epidemiology of Chlamydia in the United States Debra J. Mosure, Ph.D. Division of STD Prevention Centers for Disease Control and Prevention March 8, 2004.
Repeat Chlamydial Infections in Region III Family Planning Clinics: Implications for Screening Programs Pamela G. Nathanson, Family Planning Council, Inc.
Organizing data in tables and charts: Criteria for effective presentation Jane E. Miller, Ph.D. Rutgers University.
Chlamydia Sexually Transmitted Disease Surveillance 2008 Division of STD Prevention.
Screening males for chlamydial infection in detention settings Charlotte K. Kent, MPH.
The Body of Power Dr. Kimberly Brodie Health Behavior Theory MPH 515 Sara Quale Dec. 16, 2013 Combatting the Spread of Sexually Transmitted Disease in.
Using Test Kit Allotments to Reduce Chlamydia Screening in Low Risk Females for Re-allocation to Higher Risk Populations and Higher Yield Venues Rabins.
STD Knowledge and Practices of New York City Providers Meighan E. Rogers, MPH Bureau of STD Control, NYC DOHMH Region II IPP Meeting, May 31-June 1, 2006.
Using Qualitative Data to Contextualize Chlamydia and Birth Rates Joyce Lisbin EdD, Anna Groskin MHS, Rhonda Kropp RN MPH, Virginia Loo ABD, Julie Lifshay.
Program Collaboration and Service Integration: An NCHHSTP Green paper Kevin Fenton, M.D., Ph.D., F.F.P.H. Director National Center for HIV/AIDS, Viral.
Women’s Health in Massachusetts Highlights from the Massachusetts Behavioral Risk Factor Surveillance System (BRFSS): Health Survey Program Bureau.
RTI International is a trade name of Research Triangle Institute Untreated chlamydial infection among adolescents and young adults in Baltimore,
Re-Screening of CT Positive Clients in Region X IPP, Goldenkranz S., 1 Fine D. 1 1 Center for Health Training 2010 CDC STD Prevention Meeting,
American Indian/Alaska Native Epidemiological Profile Jennifer Kawatu, RN, MPH November 9,
Trends in Clinic Visits and Diagnosed C. trachomatis and N. gonorrhoeae Infections Following the Introduction of a Co-Pay in an STD Clinic C. Rietmeijer.
Region I IPP Infrastructure Updates Advisory Board Meeting November 12, 2009 Boston, MA.
Region I IPP Clinic Staff and Provider Assessment Kim Watson, Jennifer Kawatu.
HIV Prevention in Kenya: Lessons Learned from the 2007 Kenya AIDS Indicator Survey Carol Ngare KAIS TWG Member, NASCOP-MOH Prevention Summit 2008 HIV Prevention.
US Virgin Islands IPP: Use of Limited Resources Taetia Phillips-Dorsett, MS Territorial Director, USVI DOH STD/HIV/TB Program Region II IPP Advisory Meeting.
Providing Comprehensive Reproductive Health Services for Men Visiting Clinics for Sexually Transmitted Infections Kees Rietmeijer, MD, PhD, MSPH Colorado.
SSuN: MSM prevalence monitoring and HIV Testing in STD Clinics Kristen Mahle & Lori Newman SSuN Call #3 Oct 30, 2008.
Region I IPP Infrastructure Updates Advisory Board Meeting June 15, 2010 Boston, MA.
Collecting Site Positivity Data in Region I Andee Krasner, MPH Region I IPP Advisory Board Meeting.
Pilot Study: Re-screening Adolescent and Young Adult Women for Chlamydia Infection Alison Muse NYSDOH Bureau of STD Control Region II IPP meeting November.
Region II IPP Data & Infrastructure Performance Measures Kelly Opdyke, MPH Region II IPP Advisory Committee Mtg May 16-17, 2007 Cicatelli Associates Inc.
Gaps in knowledge and practice among postpartum women living with HIV in Swaziland Charlotte Warren Rachel Shongwe, Nelisiwe Sikhosana, Joshua Kikuvi and.
Region I Infertility Prevention Project June 9-10, 2008 Wells Beach, Maine Steven J. Shapiro Infertility Prevention Project Coordinator CDC/CCID/NCHHSTP/DSTDP/PTB.
IPP Measures of Effectiveness Utilization of Data to Evaluate and Inform Project Activities December 12, 2007 Kelly Morrison Opdyke, MPH Region II Infertility.
Integration of Male Services into Family Planning Settings April 4, 2006 Norman Clendaniel Delaware Division of Public Health.
Infrastructure Update Jennifer Kawatu Kim Watson Andee Krasner
Integrating Family Planning and VCT Services. Clients Seeking HIV-related Services Why Integrate HIV and RH Services Share common needs and concerns:
Targeting Chlamydia Screening Resources Region II IPP Advisory Meeting May 31, 2006 Kelly Opdyke, MPH Cicatelli Associates Inc.
Predicting Pregnancy Risk among Women Attending an STD Clinic Judith Shlay MD, MSPH Denver Public Health September 21, 2008 CityMatCH Conference.
Increasing Incidence of Gonorrhea in California (the talk formerly known as: “Gonorrhea Drips on in California”) Michael C Samuel 1, Virginia Loo 1, Denise.
Focus Area 25 Sexually Transmitted Diseases Progress Review July 21, 2004.
NYC DOHMH BSTDC School-Based Education, Screening and Treatment Pilot Program Meighan Rogers, MPH Bureau of STD Control, NYC DOHMH Region II IPP Meeting,
Trends in Neisseria gonorrhoeae Incidence in Washington State Region X GC Meeting Trends in Neisseria gonorrhoeae Incidence in Washington State Region.
Region I IPP Data Presentation Advisory Board Meeting June 2008 Wells, ME.
Decoding the USPSTF By: Dr Vikram Arora Heritage Valley Health System.
Region II Infertility Prevention Project Advisory Committee May 16-17, 2007 New York, New York Steven J. Shapiro Infertility Prevention Project Coordinator.
IPP Infrastructure Measures of Effectiveness: Preliminary Data and Next Steps Kelly Morrison Opdyke, MPH Region II Infertility Prevention Project Cicatelli.
HIV and AIDS Data Hub for Asia-Pacific 11 HIV and AIDS Data Hub for Asia-Pacific Review in slides India.
Region I IPP Advisory Board Meeting June 14 and 15, 2010 Wells, ME Chlamydia Testing during Pregnancy Test Only (PTO) Visits.
CONCLUSIONS New Jersey’s Emergency Department HIV testing sites report higher seroprevalence than non-ED testing sites. Since University Hospital began.
Rodney C. Perkins 1, Grace K. Douglass 2, Victoria C. Ta 2, Aurnell Dright 1, Michael Fomundam 2, Ying Li 3, Michael Plankey 3 Sexually Transmitted Infection.
Seeking HIV-testing Only: Missed Opportunity for HIV Prevention?
Evaluation Report: April 1, 2015 – March 31, 2016
Universal Screening to Assess Chlamydia Prevalence and Risk Among Older Women Attending Family Planning Clinics in Wisconsin Roberta (Bobbie) McDonald.
Cost of Screening Outside of IPP Chlamydia Screening Guidelines
A study of high risk African American women, 15 to 21 years of age
FACTORS ASSOCIATED WITH RECEIPT OF HEPATITIS B VACCINE AMONG HIGH RISK ADULTS NATIONAL HEALTH INTERVIEW SURVEY, 2000 Nidhi Jain MD MPH The topic of my.
Infertility Prevention Project Coordinator CDC/CCID/NCHHSTP/DSTDP/PTB
Family Planning & STDP Brainstorming
Region I IPP Data Update Region I IPP Advisory Board Meeting
Region II IPP Performance Measure IPP CS1 and IPP CS2 Project Area Trend Report IPP CS1: Timely treatment of women with chlamydia at IPP Family Planning.
Region I IPP Data Update Region I IPP Advisory Board Meeting
Treatment Verification Rates for Chlamydia and Gonorrhea
Gonorrhea Screening: What Do the Data Tell Us?
Presentation transcript:

Chlamydia Screening Rates among Pregnancy Test Only Visits in Region I, Andee Krasner, MPH Region I IPP Infrastructure

Background National Objective of IPP Infrastructure Epidemiologic profile of pregnancy-test only clients seen in prevalence monitoring clinics

Objectives 1.Explore provider PTO screening practices among IPP supported clinics and partners 2.Provide baseline CT screening rates among women presenting for pregnancy-test only visits from by age and by race/ethnicity

METHODS

I. Provider Survey 2009 electronic survey N=295 from all six states Respondents from FP clinics, CHCs, STD clinics and Other 59 (20%) of providers did not answer PTO questions

II. PTO Screening Rates Data from Region I Family Planning Data System Data from Title X Family Planning sites are largely representative of IPP – Both have family planning clinics, school-based clinics, and Department of Youth Services (DYS) sites – The Title X data will not be representative of state-funded STD clinics and adult correctional facilities

Definition of PTO? General Definition Primary reason for visit= Pregnancy Test Variable Definition A clinic visit by a woman coming into family planning clinics for pregnancy testing who did not receive a physical examination, injection, or STD screening (other than CT, GC, or HIV) at the time of the visit. Includes: Visits with pregnancy test (PT) and zero or more of the following tests during the same visit: CT test, GC test, HIV test, emergency contraception, or blood pressure measurement. Note: No existing national definition for PTO

Age Categories for Analysis Used 24 and younger for age cut off in all states to reflect highest screening rates

Limitations Constructed PTO variable based on visit type response options – dont know primary intention of visit No national CT screening rates among PTO visit to compare to – used pelvic exam screening rates as bench mark No CT positivity rates in Title X Family Planning dataset – rely on published literature to suggest that positivity in PTO visits supports screening (4.7%-13.7%)

RESULTS

I. Provider Knowledge, Attitudes, and Behavior Around CT Screening During PTO Visits PTO visit feasible at clinic level 6 states use NAAT testing; capacity to do urine-based or self-collected vaginal swab Used urine based screening already: – 99% for men – 93% for women

Provider Practice The majority (86%) responded that PTO visits were fewer than 20% of their visits Variability in clinical practice from state to state ̶Our clinic policy is to only do CT testing during scheduled visits and annual exams (not walk in PTO visit) ̶Range of agreement in Region I states from 2.3% - 46%

Provider Attitude Interest in and commitment to increasing screening at PTO visits in the region – Providers indicate that they have time to CT screen on PTO visit – Providers were most strongly influenced to change their screening practices by evidence of higher positivity

II. CT Screening Rates Among PTO Visits by Age Year % Women with CT Screen at PTO Visit

CT Screening Rates Among PTO Visits by Race ( combined)

CT Screening Rates Among PTO Visits by State

Comparison of CT screening in PTO and Pelvic Exam Visits In all states, chlamydia screening among pelvic exams was much more common than the CT screening among PTO visits Chlamydia screening rates among PTO visits were never higher than 30%, while screening rates among pelvic exams hovered around %

What do the data mean?

CT Screening Rates among PTO Visits PTO screening in Region I – Increasing over 5 years (without national screening guidance) PTO Screenings according to National and state CT screening recommendations – Teens most often screened during PTO visits – women should also be emphasized – Women 25 and older least likely to receive screening at PTO visit

Positivity Rates Support CT Screening in PTO Visits Positivity in PTO visits has been shown to be 4-13% in the literature Region I: 5.1% PTO Positivity of Q1/Q2 Region I: 5.1% As high as 8.2% in ME (small numbers <50 visits)

% PTO Visits, Family Planning Clinics Q1/Q2 2011

Percent Positive Among PTO/Non-PTO Visits in FP Clinics, Q1/Q Women < 25/26

How to increase CT screening in future PTO visits? Clinicians say they have time to do a CT screening during PTO visit Clinicians are influenced by data showing higher positivity PTO variable on lab slips allow us to provide data on positivity

Ideas to Increase CT screening in PTO visits Provider and staff education about state IPP CT screening guidelines and CT positivity among PTO visits Establish standing orders, written policies and protocols that assume CT screening among PTO visits Monitor CT positivity among PTO visits and share data

CONCLUSIONS

Widespread commitment to evidence-based practice in Region I CT positivity supports increased screening in PTO visits Although not widely practices in 2009, evidence suggests CT screening among PTO visits is steadily increasing Commitment from Region I AB to monitor PTO visits (lab slip changes)